AN2 Therapeutics
(NASDAQ:ANTX)
$2.0408
-0.0192[-0.93%]
Last update: 5:07PM Get Real Time Here

AN2 Therapeutics Stock (NASDAQ:ANTX), Short Interest Report

Short interest for AN2 Therapeutics gives investors a sense of the degree to which investors are betting on the decline of AN2 Therapeutics's stock. Short interest data is updated every two weeks.

Short Interest
693.8K
Short Interest %
3.61%
Days to Cover
6.62
Get Alert
ANTXAN2 Therapeutics, Inc. Common05/24/20243.61%19,235,824693,840104,8036.62Get Alert
ANTXAN2 Therapeutics, Inc. Common05/09/20243.83%19,235,824736,89599,9527.37Get Alert
ANTXAN2 Therapeutics, Inc. Common04/24/20242.39%19,235,824460,513482,7981Get Alert
ANTXAN2 Therapeutics, Inc. Common04/09/20241.32%20,644,536272,509361,3271Get Alert
ANTXAN2 Therapeutics, Inc. Common03/26/20241.55%20,615,606319,420403,9781Get Alert
ANTXAN2 Therapeutics, Inc. Common03/11/20241.43%20,615,606295,295628,9061Get Alert
ANTXAN2 Therapeutics, Inc. Common02/27/20241.63%20,615,606336,249896,7681Get Alert
ANTXAN2 Therapeutics, Inc. Common02/09/20241.36%20,615,606280,320103,9082.7Get Alert
ANTXAN2 Therapeutics, Inc. Common01/24/20241.47%20,615,606302,10091,2593.31Get Alert
ANTXAN2 Therapeutics, Inc. Common01/10/20241.43%20,615,606294,38996,8593.04Get Alert
ANTXAN2 Therapeutics, Inc. Common12/27/20230.81%20,615,606166,643148,6781.12Get Alert
ANTXAN2 Therapeutics, Inc. Common12/11/20231.37%20,615,606282,09765,7004.29Get Alert
ANTXAN2 Therapeutics, Inc. Common11/27/20231.55%20,615,606319,01838,2078.35Get Alert
ANTXAN2 Therapeutics, Inc. Common11/09/20231.24%20,580,391255,77026,8639.52Get Alert
ANTXAN2 Therapeutics, Inc. Common10/24/20231.11%20,580,391227,44741,5975.47Get Alert
ANTXAN2 Therapeutics, Inc. Common10/10/20230.64%20,580,391131,462128,1881.03Get Alert
ANTXAN2 Therapeutics, Inc. Common09/26/20230.77%20,580,391159,23275,1432.12Get Alert
ANTXAN2 Therapeutics, Inc. Common09/12/20230.75%20,580,391153,70482,0331.87Get Alert
ANTXAN2 Therapeutics, Inc. Common08/24/20230.65%20,580,391133,7918,54415.66Get Alert
ANTXAN2 Therapeutics, Inc. Common08/09/20231.32%10,300,613135,68322,3906.06Get Alert
ANTXAN2 Therapeutics, Inc. Common07/25/20231.54%10,300,613158,64331,1685.09Get Alert
ANTXAN2 Therapeutics, Inc. Common07/12/20232.04%10,300,613210,047412,8061Get Alert
ANTXAN2 Therapeutics, Inc. Common06/27/20233.76%10,300,613387,63964,4886.01Get Alert
ANTXAN2 Therapeutics, Inc. Common06/09/20233.24%10,300,613333,87136,3269.19Get Alert
ANTXAN2 Therapeutics, Inc. Common05/24/20232.58%10,300,613265,53539,8936.66Get Alert
ANTXAN2 Therapeutics, Inc. Common05/09/20232.45%10,300,613252,19019,11713.19Get Alert
ANTXAN2 Therapeutics, Inc. Common04/25/20232.20%10,300,613226,81518,07212.55Get Alert
ANTXAN2 Therapeutics, Inc. Common04/12/20231.93%10,300,613198,80741,4054.8Get Alert
ANTXAN2 Therapeutics, Inc. Common03/24/20231.53%10,276,819157,68119,3688.14Get Alert
ANTXAN2 Therapeutics, Inc. Common03/09/20231.43%9,991,025143,14426,3785.43Get Alert

Looking for the most shorted stocks?

People Also Watch